Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors
NCT07299747
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
255
Enrollment
INDUSTRY
Sponsor class
Conditions
Participants With Advanced Solid Tumor Malignancies
Interventions
DRUG:
VBC103
Sponsor
VelaVigo Bio Inc